nevadensin has been researched along with Liver Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Adams, TB; Alhusainy, W; Iatropoulos, MJ; Jeffrey, AM; Rietjens, IM; Taylor, S; Williams, GM | 1 |
Han, JX; Shen, ZM; Sun, YF; Xu, B; Yang, JL | 1 |
Gao, Y; Li, D; Li, M; Lin, H; Shi, H; Wang, G; Wang, X; Yi, F; Yin, Y; Zou, Y | 1 |
Liu, X; Meng, Z; Sun, Z; Wang, D; Yang, A; Zhang, P; Zhang, X | 1 |
4 other study(ies) available for nevadensin and Liver Neoplasms
Article | Year |
---|---|
The natural basil flavonoid nevadensin protects against a methyleugenol-induced marker of hepatocarcinogenicity in male F344 rat.
Topics: Animals; Body Weight; Carcinogens; DNA Adducts; Eugenol; Flavones; Liver; Liver Neoplasms; Male; Organ Size; Rats; Rats, Inbred F344 | 2014 |
[Cultured human hepatoma cells (BEL-7404) for anticancer drugs screening].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Evaluation, Preclinical; Flavones; Flavonoids; Harringtonines; Homoharringtonine; Humans; Liver Neoplasms; Tumor Stem Cell Assay | 1985 |
The abrogation of GRP78 sensitizes liver cancer cells to lysionotin by enhancing ER stress-mediated pro-apoptotic pathway.
Topics: Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endoribonucleases; Heat-Shock Proteins; Humans; Liver Neoplasms; Protein Serine-Threonine Kinases; RNA, Small Interfering | 2023 |
Lysionotin induces apoptosis of hepatocellular carcinoma cells via caspase-3 mediated mitochondrial pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Caspase 3; Cell Line, Tumor; Cell Proliferation; Flavones; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mitochondria; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2021 |